PetVivo Holdings Inc - Asset Resilience Ratio
PetVivo Holdings Inc (PETV) has an Asset Resilience Ratio of 2.18% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is PetVivo Holdings Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2025)
This chart shows how PetVivo Holdings Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see PETV current and non-current assets.
Liquid Assets Composition Over Time
This chart breaks down PetVivo Holdings Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read total liabilities of PetVivo Holdings Inc for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $150.00K | 2.18% |
| Total Liquid Assets | $150.00K | 2.18% |
Asset Resilience Insights
- Limited Liquidity: PetVivo Holdings Inc maintains only 2.18% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
PetVivo Holdings Inc Industry Peers by Asset Resilience Ratio
Compare PetVivo Holdings Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medtronic plc
SA:MDTC34 |
Medical Devices | 7.82% |
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Biosynex
PA:ALBIO |
Medical Devices | 3.35% |
Annual Asset Resilience Ratio for PetVivo Holdings Inc (2016–2025)
The table below shows the annual Asset Resilience Ratio data for PetVivo Holdings Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 1.61% | $150.00K | $9.34 Million | -- |
| 2024-03-31 | 0.00% | $0.00 | $3.12 Million | -- |
| 2018-03-31 | 0.00% | $0.00 | $1.57 Million | -- |
| 2017-03-31 | 0.00% | $0.00 | $1.90 Million | -- |
| 2016-03-31 | 0.00% | $0.00 | $16.69 Million | -- |
About PetVivo Holdings Inc
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company's lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for … Read more